市场调查报告书
商品编码
1541734
2024-2032 年按技术(乳房断层合成、CAD、数位)、产品(胶片萤幕系统、数位系统、模拟系统、活检系统、3D 系统)和区域分類的乳房 X 光摄影市场报告Mammography Market Report by Technology (Breast Tomosynthesis, CAD, Digital), Product (Film Screen Systems, Digital Systems, Analog Systems, Biopsy Systems, 3D Systems), and Region 2024-2032 |
IMARC Group年,全球乳房X光摄影市场规模达25亿美元。
乳房X光检查是一种非侵入性医学影像和诊断程序,使用低剂量X射线筛检乳房组织中的恶性肿瘤细胞。乳房X光检查或乳房X光检查使用模拟、数位、电脑辅助检测和断层合成系统来突出显示乳房中的小肿瘤、囊肿和其他不规则现象。进行乳房X光检查是为了在没有任何症状的情况下检查是否有异常,这有助于及时治疗严重的医疗状况。通常随后进行诊断性乳房X光检查以评估任何异常的临床发现。因此,它在医院、专科诊所以及诊断和门诊手术中心中得到了广泛的应用。
全球乳癌盛行率不断上升是推动市场成长的关键因素之一。此外,大众对现有治疗替代方案以及乳癌筛检和早期诊断益处的认识不断提高,这也推动了市场成长。此外,各种技术进步,例如创新的三维、非电离和电离成像解决方案的开发,也是其他成长诱导因素。例如,全视野数位乳房 X 光摄影 (FFDM) 和数位乳房断层合成 (DBT) 系统从多个角度捕捉大量乳房影像,并将它们整合到 3D 影像集中,以产生更高精度的结果。与此一致,为公立医院和诊断中心提供具有成本效益的影像解决方案的数位乳房X光检查系统租赁服务也有助于市场的成长。其他因素,包括医疗基础设施的显着改善,以及促进公共卫生的有利政府政策的实施,预计将推动市场成长。
The global mammography market size reached US$ 2.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.8 Billion by 2032, exhibiting a growth rate (CAGR) of 7.5% during 2024-2032.
Mammography refers to a non-invasive medical imaging and diagnostic procedure that uses low-dose X-rays to screen breast tissues for malignant tumor cells. A mammography exam, or mammogram, uses analog, digital, computer-aided detection and tomosynthesis systems to highlight small tumors, cysts and other irregularities in the breasts. Screening mammography is conducted to check for abnormalities in the absence of any symptoms, which can aid in timely treatment of a serious medical condition. It is usually followed by a diagnostic mammogram to evaluate any abnormal clinical findings. As a result, it finds extensive applications in hospitals, specialty clinics and diagnostic and ambulatory surgical centers.
The increasing prevalence of breast cancer across the globe is one of the key factors driving the growth of the market. Moreover, increasing awareness regarding the available treatment alternatives and the benefits of screening and early diagnosis of breast cancer among the masses is providing a thrust to the market growth. Additionally, various technological advancements, such as the development of innovative 3-Dimentional, non-ionizing and ionizing imaging solutions, are acting as other growth-inducing factors. For instance, Full-field digital mammography (FFDM) and Digital Breast Tomosynthesis (DBT) systems capture numerous images of the breast from multiple angles and integrates them into a 3D image set for the generation of results with enhanced precision. In line with this, the availability of rental services for digital mammography systems for public hospitals and diagnostic centers providing cost-effective imaging solutions is also contributing to the growth of the market. Other factors, including significant improvements in the healthcare infrastructure, along with the implementation of favorable government policies promoting public health, are anticipated to drive the market toward growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global mammography market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on technology and product.
Breast Tomosynthesis
CAD
Digital
Film Screen Systems
Digital Systems
Analog Systems
Biopsy Systems
3D Systems
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Analogic Corporation, Carestream Health (Onex Corporation), Fujifilm Holdings Corporation, General Electric Company, Hologic Inc., Konica Minolta Inc., Metaltronica S.p.A., Mindray Medical International Limited, Koninklijke Philips N.V., Planmed Oy (Planmeca Oy) and Siemens AG.